International safety notice
ANTIBODY TO ACQUIRED HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, TYPE 2 AND TYPE 1 SUBGROUP O (HIV)
Brazil / Anvisa · BRA · May 22, 2015
Key facts
| Title | ANTIBODY TO ACQUIRED HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, TYPE 2 AND TYPE 1 SUBGROUP O (HIV) |
|---|---|
| Regulator | Brazil / Anvisa |
| Country | BRA |
| Brand | ADVIA Centaur HIV 1/0/2 Enhanced (EHIV), registration: 10345161854, risk class IV; |
| Manufacturer | DETENTOR DO REGISTRO SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA CNPJ 01449930000190 ENDEREÇO AV MUTINGA 3800 7º ANDAR PIRITUBA SÃO PAULO FABRICANTE SIEMENS HEALTHCARE DIAGNOSTICS INC ESTADOS UNIDOS 511 BENEDICT AVENUE TARRYTOWN NY 10591 |
| Models | 52901147, 47542143, 51462145, 48444143, 45502141, 10345161854, 44563141 |
| Date | May 22, 2015 |
| Regulator page | anvisa.gov.br |
At a glance
- No Recall
- No Field safety notice
- 1–9 Matching device models in FDA data
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1